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STUDIES ON THE IN VITRO DRUG RESISTANCE OF
E. COLI TOWARDS MIXTURES OF SULFONAMIDES*
E. GRUNBERG AND D. ELDRIDGE
Although it is a well-known fact that drug resistance towards
sulfonamides is easily obtained after a comparatively small number of
exposures of the sensitive microorganisms to these drugs in vitro or in vivo,'
there is, to our knowledge, no report in the literature concerning the
influence that mixtures of different sulfonamides might have on the
development of resistant strains.
The wide use of combinations of three sulfonamides, which is due to the
better solubility and the curtailing of by-effects particularly in reference to
the kidneys,'6" made it seem desirable to investigate the influence of sulfon-
amide combinations on the development of drug resistance of bacteria. The
individual components of these mixtures, as far as they were available,
were of course studied at the same time. In addition, a new sulfonamide,
3,4-dimethyl-5-sulfanilamidoisoxazole (Gantrisin) was also tested because
no experimental data on drug resistance were available for this compound.
The development of drug resistance to this compound has apparently not
been observed clinically and in one report the absence of this tendency has
been specifically stressed.2 The results of these studies are given in the
present paper.
Materials and methods
Two groups of sulfonamide combinations were investigated. The first
group comprised five sulfonamide combinations designated A, B, C, D,
and E which contained mixtures of sulfonamides of high activity. The first
four of this series contained the well-known combination of sulfathiazole,
sulfadiazine, and sulfamerazine, while mixture E contained sulfadiazine,
sulfamerazine, and sulfamethazine. These sulfonamides, constituting a
mixture of 33%o of each ingredient, were commercially available products.
Only one representative of a second group was included. This was
sulfonamide mixture F which contained besides sulfadiazine and sulfa-
merazine the soluble N1-sulfanilylacetamide (sulfacetamide). In addition,
the following single sulfonamides were also tested: sulfathiazole, sulfa-
diazine, sulfamerazine, sulfacetamide, and Gantrisin.*
A strain of E. coli J was used as the test organism' in all experiments.
The solutions of the sulfonamide mixtures and the single sulfonamides were made
* From the Chemotherapy Laboratories, Hoffman-La Roche, Inc., Nutley, New
Jersey.
* Sulfamethazine was not included in the experimental work since it was unavailable
at the time of these studies.
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by dissolving the tablets or powder in alkali, filtering and adjusting to pH 7.0 to 7.5.
The technique described below was used in rendering E. coli resistant to the
sulfonamides in zvtro. The organism was grown in test tubes containing synthetic
medium' with decreasing concentrations of the sulfonamides or sulfonamide mixtures
made up by the serial dilution method. The range of concentrations was from 0.00049
mg./ml. to 1.0 mg./ml. except in the case of sulfacetamide where the highest concen-
tration used was 5.0 mg./ml. After twenty-four hours' incubation, the first tube
showing good growth was used for the inoculation of a new experiment and so on
until resistance to 1.0 mg./ml. or 5.0 mg./ml. (sulfacetamide) was achieved.
The inoculum consisted of 0.05 ml. of a 10 dilution of the culture of E. coli
(strain J).
The experiments were extended to a period of approximately four weeks or to the
time at which full growth was obtained in the highest concentration.
TABLE 1
DRUG RESISTANCE OF E. COLI TOWARDS DIFFERENT SULFONAMIDES IN VITRO
Passage Growth inhibiting concentration in mg./ml.
number Sulfathiazole Sulfadiazine Sulfamerazine Gantrisin Sulfacetamide
0 0.00098 0.00195 0.00195 0.00049 0.0195
3 0.0039 0.0039 0.0156 0.0039 0.625
6 0.0312 0.0312 0.0625 0.0312 2.5t
12 0.5 0.125 +1.0 0.0625 ....
18 0.5 0.25 .... 0.25 ....
21 0.5 0.25 .... 0.5 ....
26 +1.0* +1.0 .... +1.0 ....
* + 1.0 = growth in 1.0 mg./ml.
t Strain was + 5.0 in the seventh passage.
Experimental
In preliminary experiments it was determined how many passages
through drug-containing medium were required to render a strain resistant
to 1.0 mg./ml. of the single sulfonamides. The results of these experiments
are given in Table 1.
The data in Table 1 which represent selected steps in the development of
drug resistance show that sulfadiazine, sulfathiazole, and Gantrisin ren-
dered the strain of E. coli J resistant to 1.0 mg./ml. after twenty-six
passages. The progression of the loss of sensitivity was in all instances
almost identical. Comparatively fast development of drug resistance was,
however, observed in two instances. The initially highly active sulfa-
merazine rendered the strain resistant towards the 1.0 mg./ml. concentra-
tions in only twelve passages. Sulfacetamide appeared not only considerably
less active than the other four sulfonamides, but resistance developed so
fast that the strain was no longer influenced by a concentration of 0.625
mg./ml. after three passages and was completely resistant to 5.0 mg./ml.
after seven passages.
185YALE JOURNAL OF BIOLOGY AND MEDICINE
The observations in this table were accurately reproducible. Identical
experiments to those given in Table 1 were, for instance, carried out at
different times with Gantrisin and sulfacetamide. In an experiment with
Gantrisin and E. coli J carried out in May-June, 1946, the initial active
concentration was 0.00049 mg./ml. After twelve passages the active concen-
tration was 0.025 mg./ml., after eighteen passages 0.25 mg./ml., and after
twenty-six passages the resistant organism grew in a concentration of 1.0
mg./ml. The identical steps in the development of drug resistance in an
experiment in January-February, 1950 (not identical with the experiment
given in Table 1 which is based on an experiment performed during
November-December, 1949) were 0.00098 mg./ml., 0.0625 mg./ml., 0.25
TABLE 2
DRUG RESISTANCE OF E. COLI TOWARDS MIXTURES OF HIGHLY ACTIVE
SULFONAMIDES IN VITRO
Passage Growth inhibiting concentration (mg./ml.) of mixtures
number A B C D E
0 0.00195 0.00195 0.00195 0.00195 0.0039
3 0.0078 0.0156 0.0039 0.0625 0.0078
6 0.0625 0.125 0.0312 0.125 0.125
12 0.125 0.25 0.0625 +1.0 0.25
18 1.0 0.25 0.125 .... 0.5
21 +1.0* +1.0 0.5 .... 0.25
26 .... .... +1.0 .... +1.0
* + 1.0 = growth in 1.0 mg./ml.
mg./ml., and the culture finally grew in 1.0 mg./ml. after twenty-six
passages.
The experiment with sulfacetamide as given in Table 1 had been carried
out two months previously with identical results. After four passages the
strain grew in a concentration of 1.0 mg./ml. At that time this was the
highest concentration tested.
A surprisingly fast development of drug resistance towards sulfamerazine
was also observed in a second series of experiments with very similar
results. The minimal active concentration at the different steps such as
passages number 0, 3, 6, 12, and 18 were 0.00195 mg./ml., 0.0312 mg./ml.,
0.125 mg./ml., 0.5 mg./ml., and more than 1.0 mg./ml. respectively, which
constitutes an almost identical replica of the experiments in Table 1.
The results of drug resistance experiments with the sulfonamide mixtures
were, as a rule, very similar to those with the single drugs. Table 2 shows,
in condensed form, the development of drug resistance towards the five
mixtures which were characterized as mixtures of highly active sulfon-
amides. The figures given in Table 2 indicate that resistance to the highest
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concentration tested in these experiments, namely, 1.0 mg./ml., was
obtained in twenty-one to twenty-six passages in increasing concentrations
of the drug mixtures. Only one of these mixtures produced a resistant
strain much faster despite the fact that this agent, mixture D, contained the
same constituents (sulfadiazine, sulfathiazole, and sulfamerazine) as mix-
tures A, B, and C. The experiment was, therefore, repeated with a freshly
prepared solution of mixture D once again starting the exposure of the
parent strain of E. coli to the drug. The results of this experiment were
as follows:
Passage 0: 0.00098 mg./ml.
Passage 3: 0.0039 mg./ml.
Passage 4: 0.0312 mg./ml.
Passage 6: 0.125 mg./ml.
Passage 9: 0.5 mg./ml.
Passage 10: +1.0 mg./ml.
TABLE 3
DRUG RESISTANCE OF E. COLI TowARDs MIXTURE F IN VITRO
Passage Growth inhibiting concentration in mg./ml.
number Experiment 1 Experiment, 2
0 0.00049 0.00049
1 0.0039 0.0039
2 0.0039 0.0078
3 0.0078 0.0078
4 0.0156 0.0156
5 0.0156 0.0625
6 0.0312 0.125
7 0.0312 0.125
8 0.0625 0.25
9 0.0625 0.25
10 0.125 0.5
11 0.125 0.5
12 +1.0* +1.0 -
* + 1.0 = growth in 1.0 mg./ml.
It seemed, therefore, that the tendency to produce drug resistance more
rapidly than other compounds was overcome by the presence of sulfathia-
zole and sulfadiazine in case of mixtures A, B, and C, but became
occasionally manifest, e.g. in mixture D.
The experiments with mixture F appeared particularly interesting
because this combination contained two sulfonamides of high initial activity,
sulfadiazine and sulfamerazine, and one, sulfacetamide, with low initial
activity. From the point of view of development of drug resistance the
mixture contained two components with a tendency to rapid appearance of
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drug fastness. It seemed doubtful that the presence of sulfadiazine might
counteract the influence of the two other components.
Table 3 shows that this was indeed the case. Two experiments carried
out with the same strain but two months apart clearly demonstrate that
resistance to the final dose of 1.0 mg./ml. was accomplished after twelve
passages. The speed with which the strain became drug resistant closely
resembled that of sulfamerazine alone, indicating that the presence of sulfa-
diazine was not sufficient to counteract the influence of two sulfonamides
which tend to render a strain resistant rapidly.
Comparative experiments with Gantrisin were included with these tests
as well as experiments to show that the sensitivity of the parent strain did
not change during the time of these experiments. In fact, the strain of
E. coli J has kept its sensitivity to sulfonamides constant for the last
four years.
Discussion
Recentexperience with combination therapy has shown that combinations
of drugs with different sites of attack might produce an interference effect
as far as the development of drug resistance is concerned."10 This possibility
appeared remote in the case of sulfonamides, particularly when one con-
siders the fact that resistance towards one sulfonamide tends to overlap to
the entire group of these agents. The present study on drug resistance of
E. coli induced by exposure to sulfonamides or their mixtures seems to
confirm this fact, since mixtures showed the same tendency to render
E. coli resistant as did their individual components.
Sulfonamides of high activity and one sulfonamide of comparatively low
bacteriostatic effect were included in the experiments on the development
of drug resistance of E. coli. The drugs also differed as to the speed with
which drug resistance was obtained. If we may adopt the term coined by
Paul Ehrlich8 and later extended by Schnitzer8 with regard to drug resist-
ance with arsenicals, we could distinguish between compounds of high
avidity, e.g. sulfathiazole and sulfadiazine, which produce drug resistance
comparatively slowly, and those of low avidity which like sulfacetamide and
sulfamerazine induce drug resistance much more rapidly. Drug resistance
of a strain of E. coli occurred slowly when the culture was exposed to the
first group, namely, sulfonamides of high activity and high avidity. The
presence of these drugs in combined preparations was also sufficient to
overcome the influence of sulfamerazine which is characterized by high
activity and low avidity. One example was found, however, in which a
mixture of sulfathiazole, sulfadiazine, and sulfamerazine showed the low
degree of avidity characteristic of the last named compound. In one
mixture (F) which was a combination of one sulfonamide of high activity
and high avidity + one sulfonamide of high activity and low avidity
+ oneofboth lowactivity and low avidity, drug resistance occurred rapidly.
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Summary
1. In vitro experiments with E. coli carried out for the study of drug
resistance towards sulfonamides showed that one can differentiate three
types of sulfonamides according to initial bacteriostatic activity and speed
of occurrence of maximal- resistance: (a) sulfonamides of high initial
activity and high avidity, sulfathiazole and sulfadiazine; (b) sulfonamides
of high initial activity and low avidity, sulfamerazine; and (c) sulfonamides
of both low initial activity and low avidity, sulfacetamide.
2. In the recently developed triple mixture of sulfonamides the presence
of two components of high activity and high avidity overcame, as a rule,
the influence of one component of low avidity. The presence of two com-
ponents of low avidity in a triple mixture consistently resulted in the rapid
development of a resistant strain.
3. Includedinthesestudies was work with a new sulfonamide, Gantrisin.
It belongs to the group of high initial activity and high avidity.
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